Co-treatment with JAK2 inhibitor TC101209 and panobinostat or hsp90 inhibitor AUY922 attenuates mutant JAK2-V617F levels and activity in human myeloproliferative disorder cells Meeting Abstract
| Authors: | Wang, Y. C.; Fiskus, W.; Natarajan, K.; Jillella, A.; Quadt, C.; Ataja, P.; Levine, R.; Bhalla, K. N. |
| Abstract Title: | Co-treatment with JAK2 inhibitor TC101209 and panobinostat or hsp90 inhibitor AUY922 attenuates mutant JAK2-V617F levels and activity in human myeloproliferative disorder cells |
| Meeting Title: | 50th Annual Meeting of the American Society of Hematology (ASH) |
| Journal Title: | Blood |
| Volume: | 112 |
| Issue: | 11 |
| Meeting Dates: | 2008 Dec 6-9 |
| Meeting Location: | San Francisco, CA |
| ISSN: | 0006-4971 |
| Publisher: | American Society of Hematology |
| Date Published: | 2008-11-16 |
| Start Page: | 1281 |
| End Page: | 1282 |
| Language: | English |
| ACCESSION: | WOS:000262104704357 |
| PROVIDER: | wos |
| PUBMED: | 22276298 |
| DOI: | 10.1182/blood.V112.11.3739.3739 |
| Notes: | --- - Meeting Abstract: 3739 - Poster Session - 50th Annual Meeting of the American-Society-of-Hematology - DEC 06-09, 2008 - San Francisco, CA - "Source: Wos" |
